The following data is part of a De Novo classification by Meridian Bioscience, Inc. with the FDA for Alethia Cmv Dna Amplification Assay, Alethia Cmv External Control Kit.
DeNovo ID | DEN180040 |
Device Name: | Alethia CMV DNA Amplification Assay, Alethia CMV External Control Kit |
Classification | Qualitative Cytomegalovirus Nucleic Acid-based Detection Device For Congenital Cytomegalovirus Infection |
Applicant | Meridian Bioscience, Inc. 3471 River Hills Drive Cincinnati, OH 45244 |
Contact | Jack Rogers |
Product Code | QDZ |
CFR Regulation Number | 866.3181 [🔎] |
Decision | Granted (DENG) |
510(k) Premarket Notification | Device Classification Under Section 513(f)(2)(de Novo) // Quick Links: Skip To Main Page Content Skip To Search Skip To Topics Menu Skip To Common Lin |
Review Advisory Board | Microbiology |
Classification Advisory | Microbiology |
Type | Direct |
Date Received | 2018-07-30 |
Decision Date | 2018-11-30 |
Reclassification Order: | Reclassification Order |